$1.75 Billion is the total value of BRIDGER MANAGEMENT, LLC's 37 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 37.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MDCO | Buy | MEDICINES CO | $93,552,000 | +5.2% | 2,461,240 | +35.3% | 5.34% | +5.2% |
POST | Buy | POST HLDGS INC | $91,042,000 | -3.0% | 1,172,466 | +9.4% | 5.20% | -3.0% |
GDDY | Buy | GODADDY INCcl a | $86,392,000 | +70.5% | 2,036,589 | +52.4% | 4.93% | +70.6% |
EVHC | Sell | ENVISION HEALTHCARE CORP | $83,757,000 | -3.7% | 1,336,479 | -5.8% | 4.78% | -3.7% |
SHPG | Sell | SHIRE PLCsponsored adr | $77,368,000 | -19.7% | 468,130 | -15.3% | 4.42% | -19.7% |
TPX | Buy | TEMPUR SEALY INTL INC | $65,966,000 | +60.8% | 1,235,543 | +39.9% | 3.76% | +60.8% |
GILD | Sell | GILEAD SCIENCES INC | $65,245,000 | -6.4% | 921,797 | -10.1% | 3.72% | -6.3% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $60,548,000 | +62.5% | 759,127 | +4.4% | 3.46% | +62.5% |
AWI | ARMSTRONG WORLD INDS INC NEW | $57,567,000 | -0.1% | 1,251,456 | 0.0% | 3.28% | -0.1% | |
LH | Sell | LABORATORY CORP AMER HLDGS | $57,242,000 | +1.6% | 371,361 | -5.4% | 3.27% | +1.6% |
NKTR | Sell | NEKTAR THERAPEUTICS | $54,957,000 | -20.3% | 2,811,092 | -4.3% | 3.14% | -20.3% |
AGN | Sell | ALLERGAN PLC | $54,184,000 | -18.9% | 222,896 | -20.3% | 3.09% | -18.9% |
MS | Buy | MORGAN STANLEY | $53,934,000 | +38.3% | 1,210,359 | +33.0% | 3.08% | +38.3% |
ERI | Buy | ELDORADO RESORTS INC | $53,903,000 | +74.1% | 2,695,132 | +64.7% | 3.08% | +74.2% |
WMGI | Sell | WRIGHT MED GROUP N V | $52,645,000 | -36.3% | 1,915,076 | -27.9% | 3.00% | -36.3% |
AET | New | AETNA INC NEW | $52,292,000 | – | 344,409 | +100.0% | 2.98% | – |
ZBH | New | ZIMMER BIOMET HLDGS INC | $51,765,000 | – | 403,158 | +100.0% | 2.95% | – |
HUM | Sell | HUMANA INC | $51,574,000 | -9.0% | 214,336 | -22.0% | 2.94% | -9.0% |
MRK | New | MERCK & CO INC | $50,753,000 | – | 791,899 | +100.0% | 2.90% | – |
FB | FACEBOOK INCcl a | $48,541,000 | +6.3% | 321,505 | 0.0% | 2.77% | +6.3% | |
TGTX | Buy | TG THERAPEUTICS INC | $46,685,000 | -13.3% | 4,645,265 | +0.5% | 2.66% | -13.3% |
CHTR | CHARTER COMMUNICATIONS INC Ncl a | $46,515,000 | +2.9% | 138,087 | 0.0% | 2.65% | +2.9% | |
INCY | Buy | INCYTE CORP | $46,339,000 | +24.8% | 368,034 | +32.5% | 2.64% | +24.8% |
VRSN | Sell | VERISIGN INC | $36,908,000 | -12.6% | 397,036 | -18.1% | 2.11% | -12.7% |
ADNT | ADIENT PLC | $34,464,000 | -10.0% | 527,133 | 0.0% | 1.97% | -10.0% | |
LBRDA | LIBERTY BROADBAND CORP | $33,483,000 | +0.8% | 390,292 | 0.0% | 1.91% | +0.8% | |
MGM | Sell | MGM RESORTS INTERNATIONAL | $32,477,000 | -41.4% | 1,037,935 | -48.7% | 1.85% | -41.4% |
MOH | New | MOLINA HEALTHCARE INC | $28,052,000 | – | 405,491 | +100.0% | 1.60% | – |
REGN | New | REGENERON PHARMACEUTICALS | $25,296,000 | – | 51,505 | +100.0% | 1.44% | – |
ALXN | New | ALEXION PHARMACEUTICALS INC | $25,065,000 | – | 206,006 | +100.0% | 1.43% | – |
TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $24,915,000 | -57.8% | 750,000 | -59.2% | 1.42% | -57.8% |
IPXL | New | IMPAX LABORATORIES INC | $21,592,000 | – | 1,341,143 | +100.0% | 1.23% | – |
IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $21,434,000 | -19.9% | 1,135,280 | -27.6% | 1.22% | -19.9% |
ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $21,339,000 | -26.3% | 1,524,191 | +8.2% | 1.22% | -26.3% |
PVG | PRETIUM RES INC | $15,869,000 | -10.3% | 1,651,328 | 0.0% | 0.91% | -10.2% | |
MGP | MGM GROWTH PPTYS LLC | $14,595,000 | +7.9% | 500,000 | 0.0% | 0.83% | +7.9% | |
CMG | Sell | CHIPOTLE MEXICAN GRILL INC | $14,169,000 | -61.0% | 34,053 | -58.3% | 0.81% | -61.0% |
ISLE | Exit | ISLE OF CAPRI CASINOS INC | $0 | – | -205,440 | -100.0% | -0.31% | – |
CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -329,345 | -100.0% | -0.40% | – |
OPK | Exit | OPKO HEALTH INC | $0 | – | -1,523,125 | -100.0% | -0.70% | – |
DXCM | Exit | DEXCOM INC | $0 | – | -384,723 | -100.0% | -1.86% | – |
WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -252,265 | -100.0% | -2.02% | – |
GRUB | Exit | GRUBHUB INC | $0 | – | -1,311,137 | -100.0% | -2.46% | – |
CNC | Exit | CENTENE CORP DEL | $0 | – | -841,854 | -100.0% | -3.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERISIGN INC | 40 | Q1 2023 | 5.2% |
TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
POST HLDGS INC | 33 | Q4 2022 | 6.1% |
TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
GODADDY INC | 28 | Q3 2023 | 8.9% |
CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.